New Medicines Manufacturing Centre to Strengthen UK Pharma

The UK’s pharmaceutical and fine chemical industry is accelerating development of a new generation of manufacturing processes thanks to a new £56 million medicines manufacturing innovation facility.

The state-of-the-art Medicines Manufacturing Innovation Centre (MMIC) will be located in Renfrewshire, Scotland, and led by the Centre for Process Innovation (CPI) in partnership with the University of Strathclyde, the Medicines Manufacturing Industry Partnership (MMIP), and founding industry partners, AstraZeneca and GSK.

The centre will ensure the UK is a technology and innovation leader in small molecule pharmaceutical and fine chemical manufacturing, thereby boosting the competitiveness of both sectors.

Read more

 

 

 

 

Britain’s world-leading researchers and entrepreneurs will benefit from an additional £780 million to create the technologies of tomorrow. Read more  

+ Read More

KCMC is hosted at the Centre for Process Innovation (CPI)

Would your business benefit from innovative changes to the way you do things, such as:

  • New manufacturing processes, or the improvement of existing ones, or
  • New products for existing markets and/or
  • New markets for existing products and/or
  • New products for new markets?

Find out more